Funding

  • Analysis

  • Startup Package, University of Connecticut.: 2007
  • Connecticut Research Foundation: Experiments & Simulations to Characterize Tablet Coating Process, Jun 2007 to May 2009.
  • NSF-Center of Pharmaceutical Processing Research: Numerical Modeling, Optimization and Scale-up of Pharmaceutical Milling in a Hammer mill, Jan 2010 to Dec 2011.
  • Connecticut Research Foundation: Experimentally validated numerical modeling of electrostatic effects in granular media, Jan 2010 to Dec 2010
  • University of Connecticut: Travel Grant, July 2009
  • NSF-Center for Pharmaceutical Processing and Research/Pfizer Inc.: Quantifying Drying Performance of a Filter Dryer, Experiments, and Simulation, July 2008 to Dec 2010
  • University of Connecticut: Travel Grant 2010
  • Boehringer Ingelhiem Pharmaceutical Inc. (BIPI): Computer Modeling of Pharmaceutical Manufacturing Processes, Jan 2011 – Dec 2011
  • PhRMA Foundation Starter Grant: Experimentally validated Modeling, Optimization, and Scale-up of High Shear Wet Granulation Process, Jan 2011 to May 2012
  • Boehringer Ingelhiem Pharmaceutical Inc.(BIPI): Pharmaceutical Powder Modeling and Technology, Jan 2012 – Dec 2012
  • US-Food and Drug Administration (FDA-NIPTE): Modeling of Aerodynamic Flow through MDI Spacer (VHC) and Characterization of Aerodynamic Particle Size Distribution using alternate methods, March 2012 to July 2013
  • Pfizer Inc.: Investigation of Electrostatic Behavior of Pharmaceutical Formulations, Sept 2012 to Aug 2014
  • Physical Sciences Incorporated (PSI) (subcontract from Phase 1 SBIR Grant from NIH): Organic Solvent Vapor Mass Flow Rate Monitor for Pharmaceutical Drying Operations, Sept 2012 to Aug 2013
  • NSF-Center for Pharmaceutical Processing and Research/AstraZeneca: Investigation of Mixing and Segregation in Dry Powder Inhaler (DPI) Formulations, March 2013 to February 2015
  • US-Food and Drug Administration (FDA-NIPTE): Young Investigator Award (YIA) – Understanding Electrostatic Behavior in Granular Materials: Multi-scale Models and Experiments, January 2013 to December 2014
  • NSF-Center for Pharmaceutical Processing and Research: Porous materials as excipients for solid self-nano emulsifying drug delivery systems, (PI: Lu, Co-PI: Chaudhuri) July 2014 to June 2016
  • NSF-Center for Pharmaceutical Processing and Research: Experimentally validated computational process models to predict the flow properties of pharmaceutical powders under different humidity conditions, August 2015 to July 2017
  • American Cancer Society: Activatable nanoparticles for radiotherapy of metastatic ovarian cancer, (PI: Lu, Collaborator: Chaudhuri), July 2015 to June 2019
  • US-Food and Drug Administration (FDA/NIPTE): A QbD approach to process development: Defining critical quality attributes, evaluating criticality across scales, and relating variation in CPPS/CQAS to product performance, (PI: Jim Drennen, CoPI: Chaudhuri), August 2015 to July 2017
  • NSF- I/UCRC:  Science of Heterogeneous Additive Printing of 3D Materials (SHAP3D), Timeline: 1/1/2017 – 12/31/2022, PI: Anson Ma (CBME)
  • Genentech: 3D printing for solid dosage form, Timeline: 07/01/17 – 06/30/20, PI: Chaudhuri
  • NSF-CPPR: Inkjet based 3D printing for solid oral dosage manufacturing, Timeline:08/01/17 – 07/31/19, PI: Chaudhuri
  • US Food and Drug Administration (FDA): Co-PI: B. Chaudhuri, PI: Diane Burgess, A continuous manufacturing platform for complex dosage form, September 2017 to August 2020.
  • Pfizer: PI(s): B. Chaudhuri, PI: Anson Ma, Characterization and 3D printing of placebo and modified release tablets. July 2017 to June 2018.